Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

21 Dec 2007 10:30

Embargoed Release: 10:30 hrs, Friday 21 December 2007

SOPHEON PLC ("Sopheon") TRADING UPDATE

Sopheon plc the international provider of software and services that improve the financial return from innovation and product development investments, issues a trading update. As 2007 draws to an end, we have continued to focus our efforts on closing the large pipeline of business referred to in our announcement of 25 October 2007. We have noted repeatedly in our communications to the market that the timing of individual sales can have substantial impact on our results, and this is proving a major factor as we close 2007. In the last few days it has become clear that a number of the transactions we have been focused on signing by the end of this year will not be concluded before the first quarter of 2008. In particular, a small number of large transactions comprising both new and extension deals - with a combined value potential of up to ‚£2 million in license alone, in addition to follow-on services and maintenance - have now been deferred. Our confidence that this business will still come to us remains high; we understand that the delays are due largely to the logistical challenges posed by year-end business activity within our customers' organizations, and in the majority of cases they have indicated that these transactions will be finalized during the first quarter of next year. Whilst disappointed, we continue to anticipate substantial revenue growth in our business, but frustratingly, we no longer expect this to be reflected in our financial results for the year ended 31 December 2007.

Despite the delays in certain major transactions, we have continued to sign new business. Revenue visibility for the year now stands at approximately ‚£6.1 million, and we are still pursuing a number of smaller opportunities to close in the final weeks of this year. We reached a significant milestone during the fourth quarter by signing the 100th licensee customer for our core software platform. The new customers acquired through our acquisition of Alignent Software in June, are of course over and above this milestone accomplishment.

We have also continued to make good progress with our ongoing product development activities. This month we completed two significant projects. First, we will soon release a new version of the former Alignent's Vision Strategist product planning software that incorporates portfolio management capabilities derived from our core Accolade product. This development is generating considerable interest from the existing Vision Strategist client base. Second, our product development organization has recently completed the coding for the most significant new version of Accolade release in Sopheon's history, which will extend the value and functionality of Sopheon's software for the non-process manufacturing markets, including the large aerospace, defence and automobile sectors. Market roll-out of Accolade version 7.0 will begin in the first quarter of 2008.

Separately, as announced in June 2006, Sopheon filed a certification with the US Securities and Exchange Commission ("SEC") on Form 15, to immediately suspend its duty to file reports under the Securities Act of 1934. This has saved us filing costs. However, the recent acquisition of Alignent could potentially require us to resume SEC reporting, unless Sopheon terminates its registration. Accordingly, pursuant to recently adopted Rule 12h-6(i) of the Exchange Act, we will shortly be filing a certification with the SEC on Form 15F, in order to effect such termination. Sopheon's ordinary shares are not traded on any US Stock Exchange, and this change will have no effect on the trading of Sopheon's shares on AIM or Euronext.

Also on the corporate front, we have agreed terms to extend Sopheon's equity line of credit facility with GEM Global Yield Fund Limited ("GEM") for a further two year period through to 23 December 2009. GEM has agreed to implement this extension at no cost to Sopheon. The facility has been used to raise working capital only once, in March 2004, leaving approximately 90% of the original ¢â€š¬10m facility available under the extended agreement.

Financial expectations noted above are subject to the completion of the year-end financial close and audit processes. We will provide shareholders with a further update on 25 January 2008.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Clare Verhagen Citigate First Financial Tel : + 31 (0) 205 754 010 David Newton Seymour Pierce Tel: + 44 (0) 207 107 8000About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.